Be part of the knowledge.™

Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

245

LikeLikedUnlike

1-15 of 348

Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Project Oncology®
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
- Jennifer Caudle, DO, FACOFP
  Peer
- Maxwell Llyod, MD
  Peer
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®
The Metabolic Roots of Early-Onset Colorectal Cancer
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
Project Oncology®
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Andrea Necchi, MD
  Peer
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
- Alexandria May, PharmD, BCPS
  Peer
- Nicholas Whipple, MD, MPH
  Peer
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
- Pavani Chalasani, MD, MPH
  Peer
- Timothy Yap, MBBS, PhD, FRCP
  Peer
advertisement
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
- Seth Wander, MD, PhD
  Peer
Adjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
Project Oncology®
Adjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
- Brian P. McDonough, MD, FAAFP
  Peer
- Matthew Galsky, MD
  Peer
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
- Ryan Quigley
  Peer
- Kathrin M. Bernt, MD
  Peer
- Rushabh Mehta, BS
  Peer
- Fatemeh Alikarami
  Peer
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Project Oncology®
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
- Pavani Chalasani, MD, MPH
  Peer
- Erica L. Mayer, MD, MPH
  Peer
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Project Oncology®
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
- Pavani Chalasani, MD, MPH
  Peer
- Erica L. Mayer, MD, MPH
  Peer
Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
Project Oncology®
Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
- Jacob Sands, MD
  Peer
- Aaron Lisberg, MD
  Peer
advertisement
Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
Project Oncology®
Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
- Jacob Sands, MD
  Peer
- Julia Rotow, MD
  Peer
- Xiuning Le, MD, PhD
  Peer
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
- Alexandria May, PharmD, BCPS
  Peer
- Daniel Landi, MD
  Peer
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
- Casey Cosgrove, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended